China

Growing demand and investments drive China’s ventilators market

Growing demand and investments drive China’s ventilators market

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality in the country.

China’s Renji Hospital launches IVF service app

It combines third-party assured data verification with blockchain technology.

China’s JD Health revamps online app

It has also introduced a new hotline service.

Subdued economy dampens multinational pharmas’ growth in China

Opportunities for MNCs exist largely in generics and OTC segments.

Healthcare improvements drive China’s oxygenators market

The country is expected to maintain a 50% market share in APAC through 2025.

UMP Healthcare’s GOLD™ Training Program joins the roster of winners in Healthcare Asia Awards 2021

The company took home the Primary Care Provider of the Year (China) trophy this year.

Hygeia Healthcare buys 100% stake in Etern Group for $268m

The acquisition indirectly holds 98% of Suzhou Yongding Hospital in Jiangsu.

China's local immunotherapy drugs poised for approvals

The brands could see significant adoption in more cost-conscious markets.

He Health bags internet hospital license in China

The online platform offers services such as men’s health consultations.

Chinese vaccines remain vital in developing nations despite criticisms

Developing nations face inadequate supply as developed nations stockpiled vaccines from top manufacturers.

BOQI International Medical acquires three hospitals for $24.92m

Two of the hospitals specialise in OB/GYN and traditional Chinese medicine.

Zhongshan Hospital ties up with Ping An for healthcare research

Their agreement covers service, scientific research, teaching and branding.

Swire Pacific invests in new private hospital in Shenzhen

The hospital will have a gross floor area of about 64,000 sqm, with 350 inpatient beds.

Beijing Hospital co-launches medical center for seniors

This has been established in partnership with JD Health and the Chinese Aging Well Association.

Further investment urged for Western China's pharma sector

Human rights issues are seen to have discouraged investment in the region.

China leads Asia Pacific in high-value oncology deals in 2020

China has 3,667 ongoing clinical trials for 1,761 oncological drugs as of 10 March.